Jazz Pharmaceuticals JAZZ Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.07B+19.1% | $1.2B+10.1% | $1.13B+6.7% | $1.05B+2.1% | $897.8M-0.5% | ||
| $196M+8.5% | —— | $198.2M-0.9% | $189.97M-13.9% | $180.7M-18.9% | ||
| $352.7M-31.4% | $406.21M+10.0% | $530.65M+62.9% | $358.4M+5.9% | $514M+46.1% | ||
| $732.3M-23.2% | $943.39M+5.1% | $1.07B+34.5% | $1.73B+110% | $953.7M+14.1% | ||
| $336.6M+702% | —— | $57.51M-77.9% | -$686.39M-444% | -$55.9M-184% | ||
| 31.5%+37.7pp | —— | 5.1%-19.6pp | -65.6%-85.1pp | -6.2%-13.6pp | ||
| -$39.9M+25.7% | $398.2M-20.6% | -$48.58M+17.2% | -$47.36M+23.6% | -$53.7M+18.8% | ||
| -$3.9M-160% | —— | -$1.02M-44.9% | -$13.54M-2,771% | $6.5M+144% | ||
| $299.2M+372% | —— | $9.04M-95.5% | -$735.55M-633% | -$109.8M-6,754% | ||
| $6.1M+134% | $0+100% | -$242.42M-1,568% | -$17.17M+44.0% | -$17.8M-253% | ||
| $293.1M+417% | —— | $251.41M+16.9% | -$718.47M-526% | -$92.5M-533% | ||
| 27.4%+37.7pp | —— | 22.3%+1.9pp | -68.7%-85.2pp | -10.3%-8.7pp | ||
| $4.43+391% | —— | $4.08+19.3% | -$11.74-571% | -$1.52-561% | ||
| $518M+1,238% | —— | $67.91M-74.7% | -$675.99M-426% | -$45.5M-161% | ||
| 48.5%+53.5pp | —— | 6%-19.4pp | -64.6%-84.9pp | -5.1%-13.3pp | ||
| $336.6M+702% | —— | $57.51M-77.9% | -$686.39M-444% | -$55.9M-184% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Jazz Pharmaceuticals's revenue?
- Jazz Pharmaceuticals (JAZZ) generated $4.4B in revenue over the trailing twelve months, up 9.2% year over year.
- Is Jazz Pharmaceuticals profitable?
- Jazz Pharmaceuticals is not currently profitable: it reported a net loss of $266.5M over the trailing twelve months, a -8.9% net margin.
- What is Jazz Pharmaceuticals's earnings per share?
- Jazz Pharmaceuticals's diluted EPS over the trailing twelve months is $-4.75.
- Where does Jazz Pharmaceuticals's income statement data come from?
- Every line is extracted from Jazz Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
